Melior Discovery

Melior Discovery Inc (Exton, PA, USA) has pioneered a unique high throughput in vivo pharmacology platform (theraTRACE) able to systematically identify novel indications for pre-clinical and development stage drugs. theraTRACE is widely used by both multinational pharmaceutical and start-up biopharmaceutical companies alike to fully explore the therapeutic potential of their drug candidates. Melior has also leveraged this expertise to build a high quality, onshore, preclinical services capability offering in vivo efficacy models in a broad range of therapeutic areas, pharmacokinetic evaluations, specialized animal models and bioanalytical services to drug developers worldwide

In vivo pharmacology,in vivo models of efficacy,phenotypic screening,drug repurposing,drug repositioning,drug reprofiling,multiplexing,behavioral assays,rodent models of disease,diabetes,parkinson's disease,and theratrace

Melior discovery operates in the Pharmaceutical manufacturing industry.

Melior discovery's revenue is 11m - 100m

Melior discovery has 11 - 50 employees.